Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies

Overview of attention for article published in Frontiers in oncology, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 12 X users
patent: 3 patents

Citations

dimensions_citation: 197 Dimensions

Readers on

mendeley: 204 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

PROTEOMICS-BASED STRATIFICATION OF ACUTE MYEOLID LEUKAEMIA

Application WO-2023118199-A1

World Intellectual Property Organisation (WIPO)

CO-INHIBITION OF CD47/SIRPα BINDING AND NEDD8-ACTIVATING ENZYME E1 REGULATORY SUBUNIT FOR…

Application WO-2022221304-A1

World Intellectual Property Organisation (WIPO)

ANTIBODY FORMULATION

Application WO-2021206965-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.